COMMUNIQUÉS West-GlobeNewswire

Press release: Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
17/02/2026
Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 17, 2026 . Sanofi announces today the filing of its Form 20-F with the U.S. [...]
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
17/02/2026
Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris, le 17 février 2026 . Sanofi annonce avoir déposé son Document d’Enregistrement Universel [...]
SPINEWAY : Résultats annuels 2025
17/02/2026
Ecully, le 17 février 2026 – 18h30 SPINEWAY Résultats annuels 2025 Un chiffre d’affaires en progression de + 4% Une amélioration des résultats Un potentiel de croissance renforcé Compte de résultat consolidé résumé 2025 [...]
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
17/02/2026
Consolidated net revenue of € 2,618.4 million for full year 2025, +11.8% or +8.3% on a like-for-like basis (3) at constant exchange rates (CER) EBITDA (1) of € 991.1 million, +14.5%, margin on net revenue of 37.8% [...]
Genmab Publishes 2025 Annual Report
17/02/2026
Company Announcement COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial [...]
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
17/02/2026
Media Release COPENHAGEN, Denmark; February 17, 2026 Genmab filed Form 20-F for the financial year 2025 with the U.S. SEC Genmab A/S (Nasdaq: GMAB ) a nnounced today that it has filed its Annual Report for the financial [...]
Spineway : 2025 annual results
17/02/2026
Ecully, February 17, 2026 – 7:00 p.m. SPINEWAY 2025 annual results Revenue up 4% Improved results Stronger growth potential Condensed consolidated income statement 2025 2024 Pro forma* 2024 Reported In thousands of [...]
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
17/02/2026
CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced its participation in World [...]
Earth Science Tech, Inc. Announces Initiatives to Advance Public Company Strategy; Expects Approximately $1.4 Million in Annualized Savings and Fiscal 2026 Net Income Growth of More Than 40%, from $3.3 Million to $4.7 Million
17/02/2026
Outlines strategic portfolio actions, governance enhancements and capital discipline plans to support next phase of growth MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “ [...]
Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer
17/02/2026
SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as [...]
Lite Strategy Reports Fiscal 2026 Second Quarter Results
17/02/2026
Second Quarter Performance Driven by Successful Deployment of Treasury Operations; Reflecting Commitment to Strategic Focus on Leveraging Litecoin Holdings Complemented by Disciplined Capital Allocation SAN DIEGO, Feb. [...]
Earth Science Tech, Inc. (ETST) Upgrades Audit Capabilities, Engages Semple, Marchal & Cooper, LLP as Independent PCAOB Auditor to Support Continued Expansion
17/02/2026
MIAMI, FL, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified, vertically integrated health and wellness portfolio, [...]
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
17/02/2026
Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn’s disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17 [...]
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
17/02/2026
REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the [...]
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
17/02/2026
HOUSTON, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that the Japan Patent Office (JPO) has issued a notice of allowance for Patent [...]
Solera Health Launches Intervention-Based Behavioral Health Network to Expand Whole-Person Care
17/02/2026
New network debuts with industry leaders Calm Health and Lyra Health on board to deliver behavioral health support PHOENIX, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Solera Health , the premier digital health delivery company [...]
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
17/02/2026
Access the “What This Means” segment here LA JOLLA, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural [...]
Salvin® Dental Specialties Partners With Preat® to Offer PreatLoc™ Overdenture Attachment System
17/02/2026
CHARLOTTE, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Salvin® Dental Specialties announced today a new partnership with Preat® Corporation to expand access to advanced restorative implant solutions with the introduction of [...]
Novo Nordisk A/S: The European Commission approves more effective dose of injectable Wegovy® for adults with obesity; clinical study showed people lost about 21% of their body weight on average
17/02/2026
The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy ® (semaglutide) for adults who may need extra help losing weight. It is now approved in all 27 countries in the European [...]

Pages